Cargando...
Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients
Background: Sildenafil, a phosphodiestase type 5 inhibitor, was approved in 2005 for the treatment of pulmonary arterial hypertension (PAH) in adults and is commonly used off-label for pediatric patients. Little is known, however, about sildenafil’s side effects in this population. Methods: Single i...
Guardado en:
| Publicado en: | Front Pediatr |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4353247/ https://ncbi.nlm.nih.gov/pubmed/25806361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2015.00012 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|